Nanomedicines based on trace elements for intervention of diabetes mellitus.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 23 08 2023
revised: 28 09 2023
accepted: 08 10 2023
medline: 15 11 2023
pubmed: 12 10 2023
entrez: 11 10 2023
Statut: ppublish

Résumé

Epidemiology shows that the incidence of diabetes mellitus (DM) is increasing year by year globally. Proper interventions are highly aspired for diabetics to improve the quality of life and prevent development of chronic complications. Trace elements, also known as microelements, are chemical substances that are present in our body in minute amounts. They are necessitated by the body for growth, development and functional metabolism. For the past few years, trace element nanoparticles have aroused considerable interest as a burgeoning form of nanomedicines in antidiabetic applications. These microelement-based nanomedicines can regulate glucose metabolism in several ways, showing great potential for diabetes management. Starting from the pathophysiology of diabetes, the state-of-the-art of diabetes treatment, the physiological roles of trace elements, various emerging trace element nanoparticles specific for diabetes were comprehensively reviewed in this work. Our findings disclose that trace element nanoparticles can fight against diabetes by lowering blood glucose, promoting insulin secretion, alleviating glucose intolerance, improving insulin sensitivity, ameliorating lipid profile, anti-inflammation and anti-oxidant stress, and other mechanisms. In conclusion, trace element nanoparticles can be applied as nanomedicines or dietary modifiers for effective intervention for diabetes.

Identifiants

pubmed: 37820567
pii: S0753-3322(23)01482-8
doi: 10.1016/j.biopha.2023.115684
pii:
doi:

Substances chimiques

Trace Elements 0
Hypoglycemic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115684

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

Shuxian Ruan (S)

Department of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, China.

Xiaolei Guo (X)

Office of Academic Research, Binzhou Polytechnic, Binzhou, China.

Yuehong Ren (Y)

Department of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, China.

Guangshang Cao (G)

Department of Pharmaceutics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Electronic address: cgs198041@163.com.

Huijie Xing (H)

Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, Jinan University, Guangzhou, China. Electronic address: xhj1980@jnu.edu.cn.

Xingwang Zhang (X)

Department of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, China. Electronic address: zhangxw@jnu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH